| 81.39 Delayed Data As of Jul 19 |  -1.30 / -1.57%Today’s Change | 62.01 Today|||52-Week Range 87.07 | +6.52% Year-to-Date |
| Previous close | 82.69 |
| Today’s open | 82.70 |
| Day’s range | 81.15 - 82.82 |
| Volume | 11,501,694 |
| Average volume (3 months) | 10,697,923 |
| Market cap | $213.0B |
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +9.52% |
| Earnings growth (next 5 years) | +8.40% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 25.7 |
| Price/Sales | 4.82 |
| Price/Book | 8.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.70 | -0.74% |
| PFEPfizer | -0.29 | -0.67% |
| AZNAstraZeneca | -0.61 | -1.50% |
| LLYEli Lilly and Co | -1.55 | -1.43% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $1.15 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
